EP0203099A1 - Orifice et fermeture elastique. - Google Patents

Orifice et fermeture elastique.

Info

Publication number
EP0203099A1
EP0203099A1 EP85905380A EP85905380A EP0203099A1 EP 0203099 A1 EP0203099 A1 EP 0203099A1 EP 85905380 A EP85905380 A EP 85905380A EP 85905380 A EP85905380 A EP 85905380A EP 0203099 A1 EP0203099 A1 EP 0203099A1
Authority
EP
European Patent Office
Prior art keywords
closure
port
tubular
bore
elastic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP85905380A
Other languages
German (de)
English (en)
Other versions
EP0203099B1 (fr
EP0203099A4 (fr
Inventor
Thomas A Fowles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Travenol Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Laboratories Inc filed Critical Baxter Travenol Laboratories Inc
Publication of EP0203099A1 publication Critical patent/EP0203099A1/fr
Publication of EP0203099A4 publication Critical patent/EP0203099A4/fr
Application granted granted Critical
Publication of EP0203099B1 publication Critical patent/EP0203099B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00—General identification or selection means
    • A61J2205/20—Colour codes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00—General identification or selection means
    • A61J2205/70—Audible labels, e.g. for pre-recorded info or messages

Definitions

  • This invention relates to a port and closure assembly.
  • the present invention relates to a port and elastic closure for a medical solution container.
  • elongated ports are utilized to access solutions contained in flexible containers.
  • the term ports includes, without limitation, fitments, valves, and other means for accessing a container.
  • the ports function as injection sites or means for accessing the solution in the flexible container.
  • the ports contain an open end that can receive a needle or other piercing means.
  • these flexible containers may contain parenteral solutions, peritoneal solutions, and the like.
  • An example of such a container is the VIAFLEX@ collapsible plastic container for " parenteral solutions sold by Travenol Laboratories, Inc. of Deerfield, Illinois. Fluids intended for intrabody administration must be sterile at the time of use to avoid the danger of introducing harmful agents into the body.
  • the container must be able to house the solution so that the solution is maintained and extracted under sterile conditions.
  • This requires not only that the container and its contents be in a sterile sealed condition at the time of receipt by the user, but also that no contamination of the contents occur when the container is opened by a physician, nurse, or medical technician prior to use.
  • the problem of maintaining sterility is particularly acute at the port of the container where the fluid is accessed.
  • This invention provides a port and closure assembly for use on flexible containers designed to contain pharmaceutical and other medicinal solutions.
  • the closure is designed to hermetically seal the port and cooperates with the port to produce an audible signal when the closure is removed from the port.
  • the sleeve of the closure is designed to cooperate with a rib circumscribing the port to produce a snap when the " closure is removed from the port.
  • Another advantage of the present invention is that it provides an elastic closure that aseptically seals the port.
  • a further advantage of the present invention is that it , provides an elastic closure that may be removed by the user with one hand.
  • An additional object of the present invention is to provide an elastic closure that lends itself to mechanical assembly.
  • a still further advantage of the present invention is that the closure includes ribs that aid in the molding process of the closure.
  • an object of the present invention is that it provides an outside wall structure of the port and a sleeve structure of the closure that cooperate to produce an audible signal when the closure is removed from the port.
  • Figure 1 illustrates a cross-sectional view of a preferred embodiment of the port and elastic closure of the present invention.
  • Figure 2 illustrates a cross-sectional view of another preferred embodiment of the port and elastic closure of the present invention.
  • Figure 1 illustrates the closure 10 and port 12 of the present invention.
  • the port 12 extends from a solution container 14 and functions to provide a means of accessing the solution container.
  • the solution container 14 includes an opening 16 which is in fluid communication with a lower tubular bore 18 in the port 12.
  • the port 12. includes a partition wall 20 that divides the lower tubular bore 18 from an upper tubular bore 21.
  • the partition wall 20 In order to access the container 14, and thereby the solution contained therein, the partition wall 20 must be broken or pierced. Typically, a needle or other sharp instrument is utilized to pierce the partition wall 20 and thereby access the fluid contained within the solution container 14.
  • the closure 10 functions to seal the opening 22 in the port 12. This is necessary to ensure than an aseptic environment is present within the upper tubular bore 21. If the upper tubular bore 21 is not maintained as an aseptic environment, when the partition wall 20 is pierced the fluid will be contaminated thereby introducing harmful agents into the patient°s body.
  • the closure 10 includes a guide member 24 that is designed to be received within the upper tubular bore 21.
  • the guide member 24 has an outer circumference that is less than the inner circumference of the upper tubular bore 21. Accordingly, when the guide member 24 is received within the upper tubular bore 21 a friction fit is not necessarily created.
  • the closure 10 includes a gripping member 26 that provides an area for the user to grip when it is desired to remove the closure 10 from the port 12.
  • the gripping member 26 is an elongated member that may include a rib 28. Although one rib 28 is shown, a greater or lesser number of such ribs may be located on the gripping member 26. The ribs 28 also function to aid in the molding process.
  • the gripping member 26 includes a tubular bore 30. As illustrated, the tubular bore 30 may extend for substantially the entire length of the closure 10. The tubular bore 30 provides a closure 10 that is difficult to reinsert into the port 12 after it has been removed. Thus, a tamper evident closure 10 is provided. This provides a closure 10 that allows the user to be assured that the aseptic environment within the upper tubular bore 21 of the port 12 has not been violated.
  • the closure 10 includes a sleeve member 32.
  • the sleeve member 32 is designed to cooperate with a rib member 34 located on the outer wall 36 of the tubular port 12.
  • the sleeve member 32 has an inner circumference that is less than the outer circumference of the rib member 34.
  • the sleeve member 32 surrounds the rib member 34. Because of the circumferences of the sleeve member 32 and the rib member 34, a portion 37 of the sleeve member extends outwardly around the rib.
  • the sleeve 32 seals the port 12 the sleeve 32 further includes fingers 38 that extend downwardly from the rib 34.
  • the sleeve member 32 and rib member 34 cooperate to produce an audible signal when the closure 10 is removed from the fitment 12 and the partition wall 20 has not been broken or pierced.
  • the outward portion 37 and fingers 38 cooperate with the rib member 34 to produce a "chinese fingers" effect producing an audible snap when the closure 10 is removed from the port 12 and the partition wall 20 has not been violated.
  • the audible signal provides not only an easy method of determining whether the partition wall 20 has been violated but also produces a positive psychological effect to the user and the patient.
  • the audible signal indicates to the doctor or nurse utilizing the solution container 14, and the patient who is to receive the solution, that the hermetic seal between the closure 10 and the port 12 has just been broken.
  • the sleeve member 32 and rib member 34 cooperate so that the closure 10 may be removed from the port 12 through the use of only one hand. This provides a more readily usable closure 10 in that typically the nurse or doctor is only able to utilize one hand to remove the closure.
  • the closure 10 is also user evident and does not require detail instructions.
  • the closure 10 is constructed from an ethylene propylene rubber.
  • the ethylene propylene rubber provides a closure 10 that has properties similar to closures constructed from natural rubber.
  • the preferred ethylene propylene rubber is EPDM.
  • the closure 10 may be color coded. To expedite the identification of the solution contained in the solution container 14, the closure 10 may be colored red, green, blue or other color that identifies to the user the solution in the container.
  • the closure 10 is compression molded, and the port 12 is injection molded. After the parts are molded, the closure 10 is fitted into the port 12. The closure 10 and port 12 assembly may then be steam sterilized. It is also possible to sterilize the closure 10 and the port 12 through bulk radiation sterilization and other methods known in the art.
  • the closure 10 provides a closure and port assembly that lends itself to mechanical assembly easily. To this end, the closure 10 provides a solid, nontacky surface that cooperates well with fitment attaching apparatus of packaging machines.
  • An example of such an apparatus is the heat seal press head that utilizes a walking beam in a form, fill, and seal packaging apparatus.

Landscapes

  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Closures For Containers (AREA)

Abstract

Ensemble constitué par un orifice (12) et une fermeture (10). La fermeture (10) comprend un manchon (32) et l'orifice comprend une nervure (34). Le manchon (32) possède une circonférence intérieure qui est plus petite que la circonférence extérieure de la nervure (34). L'orifice (12) et la fermeture (10) coopèrent pour produire un signal audible lorsque la fermeture (10) est retirée de l'orifice (12).
EP85905380A 1984-11-13 1985-10-29 Orifice et fermeture elastique Expired EP0203099B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67085284A 1984-11-13 1984-11-13
US670852 1984-11-13

Publications (3)

Publication Number Publication Date
EP0203099A1 true EP0203099A1 (fr) 1986-12-03
EP0203099A4 EP0203099A4 (fr) 1987-09-21
EP0203099B1 EP0203099B1 (fr) 1989-06-14

Family

ID=24692156

Family Applications (1)

Application Number Title Priority Date Filing Date
EP85905380A Expired EP0203099B1 (fr) 1984-11-13 1985-10-29 Orifice et fermeture elastique

Country Status (6)

Country Link
EP (1) EP0203099B1 (fr)
JP (1) JPS62500704A (fr)
CA (1) CA1292442C (fr)
DE (1) DE3571017D1 (fr)
WO (1) WO1986002907A1 (fr)
ZA (1) ZA858569B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2881642A1 (fr) * 2013-12-04 2015-06-10 Schaeffler Technologies AG & Co. KG Couvercle de protection

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4779997A (en) * 1987-04-27 1988-10-25 Baxter Travenol Laboratories, Inc. Closure for a port and closure assembly
US4903855A (en) * 1988-11-25 1990-02-27 Baxter International Inc. Closure and port assembly
US4892222A (en) * 1988-11-25 1990-01-09 Baxter International Inc. Port assembly for a container
NO891734L (no) * 1989-04-26 1990-10-29 Ken Heimreid Anordning ved lukke for beholdere for eventuelt infisertevaesker.
US20020104817A1 (en) * 2000-03-09 2002-08-08 Lasaitis Con A. Pull cap for a port of an administration assembly
DE102004027743A1 (de) 2004-06-07 2006-01-05 Fresenius Medical Care Deutschland Gmbh Kappe, insbesondere Desinfektionskappe, Detektionsvorrichtung für die Peritonealdialyse, Beutelset für die Peritonealdialyse und dessen Verwendung
US20090105684A1 (en) 2007-10-23 2009-04-23 Baxter International Inc. Medication port for medical fluid container

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2907489A (en) * 1956-10-17 1959-10-06 American Flange & Mfg Disposable vent plug
US3105613A (en) * 1960-05-09 1963-10-01 Baxter Don Inc Blood container
US3554256A (en) * 1968-11-08 1971-01-12 Dave Champman Goldsmith & Yama Flexible intravenous container
JPS4910155U (fr) * 1972-04-25 1974-01-28
JPS5061094A (fr) * 1973-09-28 1975-05-26
US3994412A (en) * 1976-03-11 1976-11-30 Abbott Laboratories Tamperproof breakaway port
US4046276A (en) * 1976-07-14 1977-09-06 Baxter Travenol Laboratories, Inc. Port protector cap for a container
US4303067A (en) * 1980-01-21 1981-12-01 American Hospital Supply Corporation Medical liquid bag having an improved additive port
US4484916A (en) * 1982-01-20 1984-11-27 American Hospital Supply Corporation Medical solution container and port construction

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8602907A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2881642A1 (fr) * 2013-12-04 2015-06-10 Schaeffler Technologies AG & Co. KG Couvercle de protection

Also Published As

Publication number Publication date
JPH0554790B2 (fr) 1993-08-13
DE3571017D1 (en) 1989-07-20
ZA858569B (en) 1986-06-25
WO1986002907A1 (fr) 1986-05-22
EP0203099B1 (fr) 1989-06-14
CA1292442C (fr) 1991-11-26
EP0203099A4 (fr) 1987-09-21
JPS62500704A (ja) 1987-03-26

Similar Documents

Publication Publication Date Title
US4889256A (en) Port and elastic closure
US4836397A (en) Closure for sealing a port
AU743521B2 (en) A container closure with a frangible seal and a connector for a fluid transfer device
US5454409A (en) Transfer adaptors
US6692478B1 (en) Swabbable needleless vial access
US4583971A (en) Closed drug delivery system
JP3694317B2 (ja) ポートアダプター及びプロテクター並びにこれらを有する容器
EP0554988B1 (fr) Dispositif pour mélanger
US5368586A (en) Closure for a drug-vial
WO1990006143A1 (fr) Ensemble d'ouverture et de fermeture
EP0327519B1 (fr) Dispositif pour mélanger et/ou transférer une substance
CA1292442C (fr) Orifice a fermeture elastique
US3904060A (en) Three barrier closure system for medical liquid container
GB2091229A (en) Fitments for containers from which liquid is intended to be withdrawn by a hollow needle or tube
CN114246794A (zh) 营养物质装置
US5122126A (en) Nozzle member provided with sealing membrane
CA2251267C (fr) Contenants medicaux perfectionnes
JPH0642676Y2 (ja) 輸液バック
FI952505A0 (fi) Lääkenesteitä varten olevat säiliöt
KR100360586B1 (ko) 2종의화합물을혼합하는주사장치
RU2218148C2 (ru) Сосуд для внутривенного введения лекарств
TW333462B (en) Improved medical containers
CS208991B1 (cs) Jednorázový sterilní uzávěr krevní lahve

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19860724

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE FR GB IT LI SE

RBV Designated contracting states (corrected)

Designated state(s): BE CH DE FR GB LI SE

A4 Supplementary search report drawn up and despatched

Effective date: 19870921

RBV Designated contracting states (corrected)

Designated state(s): BE CH DE FR GB LI SE

17Q First examination report despatched

Effective date: 19880304

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BAXTER INTERNATIONAL INC.

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): BE CH DE FR GB LI SE

REF Corresponds to:

Ref document number: 3571017

Country of ref document: DE

Date of ref document: 19890720

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
EAL Se: european patent in force in sweden

Ref document number: 85905380.3

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20031020

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20031021

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20031022

Year of fee payment: 19

Ref country code: CH

Payment date: 20031022

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20031125

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20031201

Year of fee payment: 19

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041029

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041030

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041031

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041031

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041031

BERE Be: lapsed

Owner name: *BAXTER INTERNATIONAL INC. (A DELAWARE CORP.)

Effective date: 20041031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050503

EUG Se: european patent has lapsed
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20041029

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050630

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

BERE Be: lapsed

Owner name: *BAXTER INTERNATIONAL INC. (A DELAWARE CORP.)

Effective date: 20041031